The Chemours Company
The Chemours Company (CC) Stock Overview
Explore The Chemours Company’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
68.50
EPS (TTM)
$0.18
ROE
0.05%
CC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of The Chemours Company (CC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.48.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 68.50 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.